王宜挺, 樊世瑞, 杨碧娟, 陈铎之, 郝小江. 基于虚拟筛选探讨菲啶类衍生物抗新型冠状病毒(SARS-CoV-2)潜力[J]. 云南大学学报(自然科学版), 2020, 42(6): 1173-1180. doi: 10.7540/j.ynu.20200259
引用本文: 王宜挺, 樊世瑞, 杨碧娟, 陈铎之, 郝小江. 基于虚拟筛选探讨菲啶类衍生物抗新型冠状病毒(SARS-CoV-2)潜力[J]. 云南大学学报(自然科学版), 2020, 42(6): 1173-1180. doi: 10.7540/j.ynu.20200259
WANG Yi-ting, FAN Shi-rui, YANG Bi-juan, CHEN Duo-zhi, HAO Xiao-jiang. Exploring the potential of phenanthridine derivatives against SARS-CoV-2based on virtual screening[J]. Journal of Yunnan University: Natural Sciences Edition, 2020, 42(6): 1173-1180. DOI: 10.7540/j.ynu.20200259
Citation: WANG Yi-ting, FAN Shi-rui, YANG Bi-juan, CHEN Duo-zhi, HAO Xiao-jiang. Exploring the potential of phenanthridine derivatives against SARS-CoV-2based on virtual screening[J]. Journal of Yunnan University: Natural Sciences Edition, 2020, 42(6): 1173-1180. DOI: 10.7540/j.ynu.20200259

基于虚拟筛选探讨菲啶类衍生物抗新型冠状病毒(SARS-CoV-2)潜力

Exploring the potential of phenanthridine derivatives against SARS-CoV-2based on virtual screening

  • 摘要: 以新型冠状病毒主蛋白酶(Mpro)和RNA依赖的RNA聚合酶(RdRp)为靶点,通过计算辅助,设计、筛选具有潜在抑制病毒活性的菲啶型化合物. 参考活性药物,设计菲啶类小分子配体库,综合运用开放源码分子对接软件Autodock vina,分子三维结构显示软件Pymol 2.1.0,对设计的菲啶类小分子配体库虚拟筛选,提取潜在活性化合物,进行结合模式和构效关系分析. 结果显示数个菲啶类衍生物能分别与Mpro和RdRp较强结合,表明经过合理设计的菲啶类衍生物有抗新型冠状病毒的潜力.

     

    Abstract: With the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) as targets, phenanthridine-type compounds for discoverying potential inhibitor on viral replication were designed and screened. Using open source software of molecular docking Autodock vina and molecular visualization system Pymol 2.1.0, the designing and virtual screening of phenanthridine-type ligand library were established. Hit compound to analyze binding mode and structure-activity relationship was extracted. Results show that specific phenanthridine derivatives can strongly bind to Mpro and RdRp respectively. It indicates the phenanthridine derivatives with rational design have great potential against SARS-CoV-2.

     

/

返回文章
返回